SureTrader
Home > Boards > US Listed > Biotechs >

Enanta Pharmaceuticals (ENTA)

ENTA RSS Feed
Add ENTA Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 8/9/2016 4:22:35 PM - Followers: 64 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ENTA
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ENTA News: Current Report Filing (8-k) 08/08/2016 04:15:53 PM
ENTA News: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2016 08/08/2016 04:01:00 PM
ENTA News: Enanta Announces the U.S. Food & Drug Administration has approved AbbVie’s New, Once-Daily VIEKIRA XR™ (dasabuvir, ombita... 07/25/2016 05:18:00 PM
ENTA News: CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir table... 07/25/2016 04:00:00 AM
ENTA News: Statement of Changes in Beneficial Ownership (4) 07/22/2016 04:41:37 PM
PostSubject
#1356  Sticky Note Global phase-3 program for ABT-493/ABT-530 (10 phase-3 trials, DewDiligence 04/19/16 03:40:30 PM
#1393   The FY3Q16 10-Q has been filed: DewDiligence 08/09/16 04:22:35 PM
#1392   Yup; I've seen it in two forums. 3 willyw 08/08/16 11:11:12 PM
#1391   I don't follow it either; I'm just reporting willyw 08/08/16 10:29:43 PM
#1390   I don't understand why ABT-493/ABT-530 would consist of DewDiligence 08/08/16 10:22:00 PM
#1389   Ah Good! I'm half surprised. They have really willyw 08/08/16 10:15:59 PM
#1388   …does [ENTA’s royalty] formula combine sales of 1st- DewDiligence 08/08/16 09:46:20 PM
#1387   Rocky wrote; with the overall HCV market going willyw 08/08/16 08:04:45 PM
#1386   The higher royalty payments will be meaningful if DewDiligence 08/08/16 06:41:10 PM
#1385   Milestone payments will make it even more like Rocky3 08/08/16 06:38:18 PM
#1384   $80M of milestone payments are coming for next-gen DewDiligence 08/08/16 05:23:31 PM
#1383   "Revenue for the three months ended June 30, biotech_researcher 08/08/16 05:21:51 PM
#1382   ENTA had $244.7M of cash at 6/30/16, a DewDiligence 08/08/16 04:10:32 PM
#1381   Viekira sales by calendar quarter: #msg-124189583. DewDiligence 07/29/16 09:24:42 AM
#1380   1. Why hasn't ABBV been able to sell DewDiligence 07/26/16 09:48:40 AM
#1379   Dew - postmeridiem 07/26/16 09:33:58 AM
#1378   FDA apparently approved the once-daily formulation of Viekira DewDiligence 07/25/16 01:20:07 PM
#1377   CHMP Grants Positive Opinion for Shorter Treatment Duration biotech_researcher 07/25/16 08:44:13 AM
#1376   FY3Q16 earnings on 8/8/16—CC at 4:40pm ET: DewDiligence 07/18/16 10:11:19 AM
#1375   Epclusa is mainly for GT3: #msg-123576073. DewDiligence 06/28/16 05:16:06 PM
#1374   FDA approves first pill to treat all forms biotech_researcher 06/28/16 05:07:07 PM
#1373   ENTA begins EDP-494 dosing in GT1/GT3 HCV patients: #msg-123405434. DewDiligence 06/20/16 08:16:16 AM
#1372   Ocaliva's label for PBC NY1972 05/31/16 11:07:23 PM
#1371   Market has no love for ENTA right now. tmoney2555 05/16/16 01:00:14 PM
#1370   Nitpick: Since ENTA uses an Oct–>Sep fiscal year, DewDiligence 05/11/16 06:57:05 PM
#1369   Jay Luly exercised and held 25K options today: #msg-122543374. DewDiligence 05/10/16 07:12:45 PM
#1368   The FY2Q16 10-Q has been filed: DewDiligence 05/10/16 04:24:05 PM
#1367   ENTA had $245.6M of cash at 3/31/16 (a DewDiligence 05/09/16 07:04:57 PM
#1366   Looks like Yahoo says that calendar year earnings Rocky3 05/09/16 06:31:05 PM
#1365   Well, it's been a brutal few days. willyw 05/05/16 08:07:02 PM
#1364   Dew, I expect you misquoted me as I biotech_researcher 05/05/16 11:08:59 AM
#1363   You announced the death of ENTA on this DewDiligence 05/05/16 10:58:07 AM
#1362   This stock is sure being ripped apart for biotech_researcher 05/05/16 10:39:04 AM
#1361   Enta, Abbvie, Gilead, post earnings release. willyw 05/01/16 01:36:39 PM
#1360   Please see #msg-122248041. DewDiligence 04/28/16 09:30:09 AM
#1359   Viekera sales: guyschmid 04/28/16 09:23:47 AM
#1358   ENTA FY2Q16 CC—5/9/16 4:30pm ET: DewDiligence 04/27/16 04:11:36 PM
#1357   V-Pak without ribavirin approved by FDA/EMA for Child DewDiligence 04/25/16 05:52:21 PM
#1356   Global phase-3 program for ABT-493/ABT-530 (10 phase-3 trials, DewDiligence 04/19/16 03:40:30 PM
#1355   Twitter poll re ABBV's priority-review voucher: DewDiligence 04/18/16 04:02:52 PM
#1354   ABT-493/ABT-530 data released today are as good as DewDiligence 04/16/16 11:28:10 AM
#1353   EASL- Real world results Abbvie 1st gen program willyw 04/15/16 09:06:13 PM
#1352   Good data, but for me the question is guyschmid 04/15/16 09:06:22 AM
#1351   Impressive ABBV/ENTA SVR rates for ABT-493/ABT-450 DewDiligence 04/15/16 08:26:46 AM
#1350   http://finance.yahoo.com/news/enanta-announces-high-svr-rates-051100649.html tmoney2555 04/14/16 01:52:13 AM
#1349   Cyclophilin data is presented tomorrow I believe tmoney2555 04/13/16 10:48:10 PM
#1348   Short interest down almost 1 million from 12/1 NY1972 04/06/16 11:19:13 AM
#1347   HIGH EFFICACY OF ABT-493 AND ABT-530 IN HCV NY1972 03/30/16 11:12:39 AM
#1346   ENTA +6% on ICL (EASL) abstracts: DewDiligence 03/30/16 10:42:54 AM
#1345   This also looks very intriguing willyw 03/16/16 11:47:55 AM
#1344   Being drawn and quartered even at average volume biotech_researcher 03/15/16 05:25:33 PM
PostSubject